SF3A2 and neoplasm: We hypothesized that SF3A2 overexpression could potentially drive tumor progression and immune evasion through several plausible mechanisms: (1) Oncogenic splicing programs: SF3A2 might promote the expression of pro-tumorigenic splice variants of genes directly involved in tumor progression and immune inhibition.